Stephens cuts California Resources stock price target to $91 on asset sale

Stephens cut California Resources' price target to $91 from $93, while retaining an Overweight rating, after the company agreed to sell non-core Uinta Basin assets for $90 million; the assets produced 5 Mboe/d in the first half of 2026. CRC's Q2 2026 revenue of $1.3 billion beat the $973.6 million consensus by 33.5%, but adjusted EPS of $0.99 missed the $1.37 estimate. The company also exceeded its 2026 Berry synergy target six months early and refinanced remaining 2029 notes, extending average debt maturity to eight years.

Analysis

The modest NAV adjustment is not the signal; the key read-through is whether monetizing a geographically distant asset converts an integration distraction into deployable cash without impairing the acquired platform’s cash-flow trajectory. At roughly $18k per flowing boe/d, the transaction value looks like a low-quality/non-core valuation rather than a benchmark for CRC’s California production. If proceeds are directed to debt reduction or high-return California development, the resulting lower complexity and improved capital intensity could support a rerating versus California-regulatory-risk peers over 6-18 months.

The near-term issue is earnings quality. A revenue beat coupled with an EPS miss and downward estimate revisions usually points to a cost, realized-price, hedging, depletion, or interest-expense gap—not simply volume strength. The market will require third-quarter evidence that incremental Berry synergies reach cash flow rather than being offset by operating costs or sustaining capital; until then, a headline synergy beat is unlikely to command a durable multiple expansion.

CRC’s longer-dated upside is principally an embedded-option story around carbon management, midstream and power/data-center infrastructure, but these initiatives should be assigned little equity value until contracts, permitted storage capacity, customer commitments and project-level returns are disclosed. Consensus may underappreciate the benefit of a longer maturity ladder in reducing refinancing sensitivity, while underpricing California-specific risks: permitting delays, carbon-policy changes, water constraints and a wider differential between California crude realizations and WTI. A sharp oil-price decline would expose the operating-cost and leverage sensitivity more quickly than it would diversified majors.

The contrarian view is that the stock need not be a pure oil-beta trade: successful asset rationalization and integration execution can narrow its discount to E&Ps even in a flat commodity tape. Conversely, the apparent valuation discount is not actionable if management raises capital spending to fund uncontracted energy-transition projects or if pro forma free cash flow fails to improve after the divestiture closes.

Key Decisions for Investors

• Do not react to the small analyst-target revision. Set an event-driven alert for the next results: initiate a CRC long only if management reaffirms or raises pro forma free-cash-flow guidance, quantifies recurring Berry synergies, and holds capital spending flat-to-lower after the asset sale closes.
• Conditional 3-6 month trade: buy CRC in the $52-$55 area after those confirmations; target $64-$68 on synergy/cash-flow validation, with a hard risk review below $47 or on a material reduction in 2027 free-cash-flow guidance. This offers approximately 2:1 upside/downside but remains contingent on disclosed leverage and hedge-book data.
• For oil-beta-neutral exposure, consider long CRC / short XOP in matched beta only after the next earnings release confirms margin recovery. The thesis is execution-driven discount compression rather than a directional crude call; exit if CRC’s realized-price-to-WTI differential widens materially or operating cost per boe rises despite synergy claims.
• Avoid assigning valuation credit to carbon capture or data-center initiatives until CRC discloses signed counterparties, permitting milestones, required equity capex and project IRRs. A funded-but-uncontracted buildout would be a thesis failure and warrants reducing exposure regardless of headline progress.
• Monitor debt-reduction use of the $90m proceeds, net-debt-to-EBITDAX, and any incremental bond issuance. Maturity extension improves liquidity, but failure to reduce leverage or rising interest expense would limit equity upside even if production and revenue remain resilient.